This local nurse practitioner experienced the challenges in securing a preceptorship firsthand before she launched a startup ...

Constellation Software shares appreciated 24% in US dollar terms in 2024 and we've had big goings-on at Constellation. Click here to read more.

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...

This article covers the Full Form of Computer (Common Operating Machine Purposely Used for Technological and Educational Research), its definition, types, and key abbreviations like CPU, RAM, ROM, and ...

Sombutpiboonphon K, et al. Fluctuation of tissue eosinophils in chronic rhinosinusitis with nasal polyp. Int Forum Allergy Rhinol. Published online December 16, 2024. doi: 10.1002/alr.23494.

Create forms, collect data, and analyse it easily with these platforms. All of the best online form builders we list below make it easy to collect customer feedback and marketing data with forms ...

These pocket-size cameras boast a full-frame sensor so there's no need to compromise on size or quality The best full-frame compact cameras are for those time when an APS-C sensor just won't cut it.

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

GSK announced that its monoclonal antibody, Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 ...